Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.
Osumi H, Shinozaki E, Osako M, Kawazoe Y, Oba M, Misaka T, Goto T, Kamo H, Suenaga M, Kumekawa Y, Ogura M, Ozaka M, Matsusaka S, Chin K, Hatake K, Mizunuma N.
Osumi H, et al. Among authors: matsusaka s.
Mol Clin Oncol. 2015 Sep;3(5):1053-1057. doi: 10.3892/mco.2015.602. Epub 2015 Jul 9.
Mol Clin Oncol. 2015.
PMID: 26623049
Free PMC article.